October 5, 2023

DRUG-GPT NAMED GOLD WINNER OF PM360 TRAILBLAZER AWARD 2023

We are thrilled to announce that Talking Medicines has been recognized as the Gold Winner in the Artificial Intelligence/Data Analytics Initiative for ‘The Perfect Marriage of Curated Data + Specialized Large Language Model in Drug-GPT at the prestigious PM360 Trailblazer Awards 2023. Since 2009, the PM360 Trailblazer Awards have celebrated outstanding achievement and innovation in healthcare marketing. The awards are judged by the PM360 Editorial Advisory Board, a distinguished group of industry experts, who evaluate initiatives in 18 distinct categories based on content, format, success in reaching the target audience, and overall quality. This year, 73 winners were recognized across various categories. These exceptional individuals and companies were honored during a gala on October 3, 2023. 

Talking Medicines is revolutionizing healthcare marketing by unlocking strategic intelligence within Conversational Data using advanced data science and artificial intelligence. Our latest achievement, Drug-GPT, allows healthcare marketers to access invaluable insights into the experiences, opinions, and sentiments of patients and healthcare professionals (HCPs) and influencers. We have developed one of the first solutions to use curated data and specialized Large Language Models (LLMs) tailored specifically for the healthcare industry. Drug-GPT sits within the PatientMetRx® data platform that leverages artificial intelligence, machine learning, and natural language processing to classify signals from unstructured sources into precise and structured intelligence. 

Subscribing agencies can now benefit from instant and accurate insights using Drug-GPT and Talking Medicines’ curated social data. With a classification accuracy rate of 95%, customers can analyze uniquely curated voices. All insights are fully compliant with healthcare sector regulations and are supported by a suite of quality control processes. These insights empower agencies to inform new business pitches, develop winning strategies, create compelling content, and monitor the impact of critical market events on customer behavior. Subscribers can explore how patients experience drugs and treatments and gain insights into the HCP perspective. The platform’s effectiveness has already been proven through a successful launch within the top 100 top healthcare advertising agencies. 

We are incredibly proud of this recognition. Elizabeth Fairley, our Chief Operating Officer and Chief Data Officer, accepted the award on behalf of Talking Medicines. She shared, “It was so amazing to be honored in this way, and this represents such hard work from the Talking Medicines team. Well done to all the winners.” 

Talking Medicines continues to push the boundaries of healthcare marketing, and this PM360 Trailblazer Award is a testament to our commitment to innovation and excellence. We are excited about the future of advanced data science and artificial intelligence in healthcare marketing and the potential that Drug-GPT  and PatientMetRx® offer.

THE TALKING MEDICINES BLOG